Pure Global
NCT05979259

Examining the Impact of a Mobile Nutrition Education App for Child Nutrition Education in Canada

Efficacy of a Digital School-Based Nutrition Education Intervention to Improve Children's Healthy Eating Knowledge, Attitudes and Behaviours
University of Ontario Institute of Technology·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Nutrition, Healthy
Drug/Device/Intervention
Serious game nutrition education intervention
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
University of Ontario Institute of Technology
Location
Oshawa, Canada
Timeline & enrollment
Phase
N/A
Start date
Sep 18, 2023
End date
Jun 01, 2025
Enrollment
672 participants
Primary outcome

Overall nutrition knowledge,Overall nutrition knowledge,Overall nutrition knowledge

Summary

This trial will test the hypothesis that a digital curriculum-based nutrition education
 intervention using the Foodbot Factory serious game (i.e., a game designed for learning)
 leads to greater student engagement and learning about nutrition, compared to conventional
 nutrition education (e.g., worksheets), among students in Grades 4 and 5 in Ontario, Canada.
 This hypothesis is based on existing research suggesting that digital serious games, when
 well-integrated into the classroom setting, promote greater student engagement, learning and
 knowledge retention.

ICD-10 classifications
Seeking and accepting physical, nutritional and chemical interventions known to be hazardous and harmfulMalnutritionObesitySequelae of malnutrition and other nutritional deficienciesNutritional deficiency, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05979259
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05979259 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Ontario Institute of Technology and is currently Recruiting. The study focuses on Nutrition, Healthy. Target enrollment is 672 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.